Monthly Program

Meeting Details

September 09, 2008
WPI Campus Center - Odeum Room
Doors open: 5:30 p.m.
Meeting: 6:00 - 9 p.m.
Cost: $15 members, $25 non-members
Pre-registration now available

Directions | Parking

September 9, 2008

Life Sciences Leader Opens New Season

Susan Windham-Bannister

Susan Windham-Bannister

There’s a biomedical boom in the Worcester area according to recent research, and Governor Deval Patrick’s signature on a $1 billion life sciences bill last June can only fuel growth in this industry. The impact of this new funding to support both research and investment in life sciences will be the subject of the Tuesday, September 9 keynote address by Susan Windham-Bannister, PhD, President and CEO of the Massachusetts Life Sciences Center (MLSC), the primary agency tasked with realizing the governor’s vision for this life sciences initiative. The 16th season of the WPI Venture Forum will open with discussion of a powerful subject for the region’s future.

Case Presentation

RXi Pharmaceuticals

Tod Woolf

Tod Woolf

RXi Pharmaceuticals is a discovery-stage biopharmaceutical company pursuing the development and potential commercialization of proprietary therapeutics based on RNA interference (RNAi) for the treatment of human diseases. President and Chief Executive Officer Tod Woolf, PhD along with his accomplished scientific advisors, including Dr. Craig Mello, believes the company is well positioned to compete successfully in the RNAi-based therapeutics market. Woolf has authored 40 patent applications and scientific publications and has twenty years of experience developing and commercializing innovative biomedical technologies.

More...

Maintained by webmaster@wpi.edu
Last modified: Aug 14, 2008, 16:25 EDT
[WPI]